Colorectal Cancer Trial, Recruiting NCT06121089 Sponsor: Moscow Clinical Scientific Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06121089
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People whose general health and ability to carry out daily activities falls within an acceptable range for this trial (rated on a standard scale used by doctors — confirm with trial site)
  • People who have been diagnosed with a specific type of colon cancer called adenocarcinoma, confirmed through laboratory testing of tissue
  • People whose cancer is at a certain stage — where the tumour has not grown too deeply into surrounding tissue and has spread to nearby lymph nodes, but has not spread to distant parts of the body
  • People whose overall physical health falls within an acceptable range on a standard medical classification scale (confirm with trial site)
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • People who have another cancer diagnosis, either at the same time or from a previous diagnosis
  • People whose tumour has grown more deeply into surrounding tissue beyond a certain point
  • People whose cancer has spread to distant parts of the body
  • People whose tumour is causing complications such as a blockage or a tear in the bowel
  • People who have already received chemotherapy before surgery for this cancer
  • People for whom surgery is not considered medically safe
  • People who are pregnant or breastfeeding
  • People with medical or mental health conditions that may affect their ability to give informed consent or follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +7(916)182-17-46

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Moscow Clinical Scientific Center
Registry
ClinicalTrials.gov
Start date
1 September 2022
Est. completion
1 January 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Overall survival.; Disease-free survival.; Disease-free survival.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov